National summary reports on pesticide residue analysis performed
Apr 6 2022 Agriculture as official laboratories: CAMP
National summary reports on pesticide residue analysis performed
Apr 20 2022 Agriculture as official laboratories: CAMP
Conseil de Communauté
Sep 24 2020 ... et le besoin étant toujours d'actualité
il fait
Oct 20 2015 CERECO / Grillon d'Or : Fabricant de céréales biologiques pour ... Relations Presse
Présentation PowerPoint
d'acteurs locaux : actualité analyse
LesGreniers bio dArmorique changent déchelle
ACTUALITÉS RÉGIONALES. Bretagne. Les'Greniers bio d'Armorique changent d'échelle. Créée en. 2005 sous l'impulsion de Gérard. Le Goff dirigeant de. Céréco
HORIZ 12_poursite
l'actualité au fur et à mesure de l'approche du CERECO et LOMAROUTE à Lieu-Saint-Amand et ... En mai 2009
LES DÉMARCHES QUALITÉ DES ENTREPRISES
CÉRÉCO. 11 ZA La Fontenelle - BP 32168. Domagné CÉRÉCO. Zone Artisanale de la Fontenelle. 35113 DOMAGNE ... actualités et envoi régulier d'une.
CONTA CTS N° 13
Oct 14 2017 www.lafranceagricole.fr/actualites/cultures/ · agroalimentaire-triballat-noyal-rachete-cereco- · 1
LE GUIDE DES LABORATOIRES DANALYSES ET
Vous pouvez suivre nos actualités sur notre La grande actualité cette année est notre inté- ... CERECO. Rue Toussaint Louverture - 93000 BOBIGNY.
TECHNICAL REPORT
APPROVED: 11 February 2022
doi:10.2903/sp.efsa.2022.EN-7216 www.efsa.europa.eu/publications EFSA Supporting publication 2022:EN-7216 National summary reports on pesticide residue analysis performed in 2020European Food Safety Authority (EFSA)
Abstract
In accordance with Article 31 of Regulation (EC) No. 396/2005, European Union (EU) Member Statesprovide to the European Food Safety Authority (EFSA) the results of their official controls on pesticide
residues in food. In this framework, the EU Member States, Iceland and Norway provided furtherinformation in the form of explanatory text outlining main findings of their control activities during the
reference year. This Technical report is the compilation of those contributions of the reporting
countries.© European Food Safety Authority, 2022
Key words: pesticide residues, food, Regulation (EC) No. 396/2005, pesticide monitoring 2020Requestor: European Commission
Question number: EFSA-Q-2021-00363
Correspondence: idata@efsa.europa.eu
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 2 EFSA Supporting publication 2022:EN-7216 Acknowledgements: EFSA wishes to acknowledge all European Union Member State bodies and other organisations that provided data for this scientific output. Suggested citation: EFSA (European Food Safety Authority), 2022. National summary reports onpesticide residue analysis performed in 2020. EFSA supporting publication 2022:EN-7216. 198 pp.
doi:10.2903/sp.efsa.2022.EN-7216ISSN: 2397-8325
© European Food Safety Authority, 2022
Reproduction is authorised provided the source is acknowledged.2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 3 EFSA Supporting publication 2022:EN-7216Summary
In the framework of the preparation of the EU report on pesticide residues under Regulation (EC)No. 396/2005, the EU Member States1, Norway and Iceland reported the results of the official controls
to the European Commission, EFSA and other Member States using the standardised reporting format (EFSA, 2021).EFSA prepared a scientific report reflecting the 2020 European Union Annual Report on Pesticide
Residues in Food (EFSA, 2022). In addition to the submission of the results in standardised reporting
format developed by EFSA (Standard Sample Description, SSD), all the reporting countries providedadditional information and a summary of their national results in a more descriptive mode compiled in
this technical report. In particular, the information was related to the competent authorities
responsible for the implementation of pesticide monitoring at national level, the objectives and design
of their national monitoring programmes, highlighting the specific characteristics and priorities of the
national control plans, and the overall results of the national control programmes. The reporting
countries also summarised the results and provided further information on follow-up actions taken and
possible reasons for samples that were found to be non-compliant with the legal limits. Some
reporting countries included a trend analysis in which the 2020 results were compared with the results
of previous years. The information also addressed quality assurance aspects, such as the accreditation
status of the laboratories responsible for official controls, and their participation in proficiency tests.
This Technical report is a compilation of that information provided to complement the scientific report
on the findings of the 2020 control year (EFSA, 2022).1 As of 31st January 2020, the United Kingdom became a third country. The United Kingdom (UK) data have been included and
evaluated in the present report because in accordance with the Agreement on the Withdrawal of the UK from the EU, and in
particular with the established transition period (i.e. until 31/12/2020), the EU requirements on data sampling also applied to
the UK.2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 4 EFSA Supporting publication 2022:EN-7216Table of contents
Abstract ......................................................................................................................................... 1
Summary ....................................................................................................................................... 3
1. Introduction ...................................................................................................................... 11
1.1. Background and Terms of Reference as provided by the requestor ...................................... 11
1.2. Interpretation of the Terms of Reference ............................................................................ 11
2. Austria ............................................................................................................................ 11
2.1. Objective and design of the national control programme ..................................................... 11
2.1.1. Objective .......................................................................................................................... 11
2.1.2. Design .............................................................................................................................. 11
2.1.3. Sampling .......................................................................................................................... 12
2.1.4. Analytical methods used .................................................................................................... 12
2.2. PPMP PO P M ŃMMNP RPO PO M P . 12
2.2.1. Key findings ...................................................................................................................... 12
2.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 13
2.3.1. Possible reasons for non-compliant samples ....................................................................... 13
2.3.2. Actions taken .................................................................................................................... 13
2.4. Quality assurance .............................................................................................................. 14
3. Belgium .......................................................................................................................... 14
3.1. Objective and design of the national control programme ..................................................... 14
3.2. PPMP PO P M ŃMMNP RPO PO M P . 15
3.2.1. Surveillance sample ........................................................................................................... 16
3.2.1.1.Fruit, vegetables, cereals and other.................................................................................... 16
3.2.2. Enforcement samples ........................................................................................................ 18
3.2.2.1.Fruit, vegetables and cereals ............................................................................................. 18
3.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 19
3.3.1. Possible reasons for non-compliant samples ....................................................................... 19
3.4. ARfD exceedances ............................................................................................................ 20
3.4.1. Actions taken .................................................................................................................... 21
3.5. Quality assurance .............................................................................................................. 21
3.6. Processing Factors (PF) ..................................................................................................... 22
3.7. Additional Information ....................................................................................................... 23
4. Bulgaria .......................................................................................................................... 23
4.1. Objective and design of the national control programme ..................................................... 23
4.1.1. Objective .......................................................................................................................... 23
4.1.2. Design .............................................................................................................................. 23
4.2. Key findings, PPMP PO P M ŃMMNP RPO PO M P . 24
4.2.1. Key findings ...................................................................................................................... 24
4.2.2. Interpretation of the results ............................................................................................... 24
4.2.3. Comparability with the previous year results ....................................................................... 26
4.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 26
4.3.1. Possible reasons for non-compliant samples ....................................................................... 26
4.3.2. ARfD exceedances ............................................................................................................ 31
4.3.3. Actions taken .................................................................................................................... 31
4.4. Quality assurance .............................................................................................................. 31
5. Croatia ........................................................................................................................... 31
5.1. Objective and design of the national control programme ..................................................... 31
5.2. Key findings, interpretation of the results and ŃMMNP RPO PO M P . 33
5.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 36
5.3.1. Possible reasons for non-compliant samples ....................................................................... 36
5.3.2. ARfD exceedances ............................................................................................................ 37
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 5 EFSA Supporting publication 2022:EN-72165.4. Quality assurance .............................................................................................................. 38
6. Cyprus ............................................................................................................................ 39
6.1. Objective and design of the national control programme ..................................................... 39
6.2. Key findings, interpretation of the results and ŃMMNP RPO PO M P . 40
6.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 41
6.4. Quality assurance .............................................................................................................. 42
6.5. Processing Factors (PF) ..................................................................................................... 43
7. Czech Republic .............................................................................................................. 43
7.1. Objective and design of the national control programme ..................................................... 43
7.1.1. Objective .......................................................................................................................... 43
7.1.2. Design .............................................................................................................................. 44
7.2. Key findings, iPPMP PO P M ŃMMNP RPO PO M P . 45
7.2.1. Key findings ...................................................................................................................... 45
7.2.2. Comparability with the previous year results ....................................................................... 46
7.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 47
7.3.1. Possible reasons for non-compliant samples ....................................................................... 47
7.3.2. ARfD exceedances ............................................................................................................ 48
7.3.3. Actions taken .................................................................................................................... 48
7.4. Quality assurance .............................................................................................................. 48
7.5. Processing Factors (PF) ..................................................................................................... 49
7.6. Additional Information ....................................................................................................... 50
8. Denmark ........................................................................................................................ 51
8.1. Objective and design of the national control programme ..................................................... 51
8.1.1. Objective .......................................................................................................................... 51
8.1.2. Design .............................................................................................................................. 51
8.2. Key findings, iPPMP PO P M ŃMMNP RPO PO M P . 52
8.2.1. Key findings ...................................................................................................................... 52
8.2.2. Interpretation of the results ............................................................................................... 53
8.2.3. Comparability with the previous year results ....................................................................... 53
8.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 54
8.3.1. Possible reasons for non-compliant samples ....................................................................... 54
8.3.2. ARfD exceedances ............................................................................................................ 54
8.4. Quality assurance .............................................................................................................. 55
8.5. Processing Factors (PF) ..................................................................................................... 55
8.6. Additional Information ....................................................................................................... 55
9. Estonia ........................................................................................................................... 57
9.1. Objective and design of the national control programme ..................................................... 57
9.2. PPMP PO P M ŃMMNP RPO PO M P . 57
9.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 58
9.4. Quality assurance .............................................................................................................. 58
10. Finland ........................................................................................................................... 59
10.1. Objective and design of the national control programme ..................................................... 59
10.1.1. Objective .......................................................................................................................... 60
10.1.2. Design .............................................................................................................................. 60
10.2. PPMP PO P M ŃMMNP RPO PO M P . 61
10.2.1. Key findings ...................................................................................................................... 61
10.2.2. Interpretation of the results ............................................................................................... 62
10.2.3. Comparability with the previous year results ....................................................................... 62
10.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................... 63
10.3.1. Possible reasons for non-compliant samples ....................................................................... 63
10.3.2. ARfD exceedances ............................................................................................................ 63
10.3.3. Actions taken .................................................................................................................... 63
11. France ............................................................................................................................ 64
11.1. Objective and design of the national control programme ..................................................... 64
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 6 EFSA Supporting publication 2022:EN-721611.1.1. Objective .......................................................................................................................... 64
11.1.2. Design .............................................................................................................................. 65
11.2. Key findings, interpretation of the results and comparability with the previous year results .... 70
11.2.1. Key findings ...................................................................................................................... 70
11.2.2. Interpretation of the results ............................................................................................... 73
11.2.3. Comparability with the previous year results ....................................................................... 75
11.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................... 76
11.3.1. Possible reasons for non-compliant samples ....................................................................... 76
11.3.2. ARfD exceedances ............................................................................................................ 80
11.3.3. Actions taken .................................................................................................................... 80
11.4. Quality assurance .............................................................................................................. 81
11.5. Processing factors ............................................................................................................. 82
12. Germany ........................................................................................................................ 82
12.1. Objective and design of the national control programme ..................................................... 82
12.2. Key findings, interpretation of the results and comparability with the previous M P . 83
12.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................... 84
12.4. Quality assurance .............................................................................................................. 92
13. Greece ............................................................................................................................ 96
13.1. Objective and design of the national control programme ..................................................... 96
13.2. PPMP PO P M ŃMMNP RPO PO M P . 97
13.3. Non-compliant samples: possible reasons. ARfD exceedances and actions taken ................. 100
13.3.1. Possible reasons for non-compliance ................................................................................ 100
13.3.2. ARfD exceedances .......................................................................................................... 103
13.4. Actions taken .................................................................................................................. 103
13.5. Quality assurance ............................................................................................................ 103
13.6. Processing factors ........................................................................................................... 104
14. Hungary ....................................................................................................................... 104
14.1. Objective and design of the national control programme ................................................... 104
14.1.1. Objective ........................................................................................................................ 104
14.1.2. Design ............................................................................................................................ 104
14.2. PPMP PO P M ŃMMNP RPO PO M P 104
14.2.1. Key findings .................................................................................................................... 104
14.2.2. Interpretation of the results ............................................................................................. 105
14.2.3. Comparability with the previous year results ..................................................................... 107
14.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 107
14.3.1. Possible reasons for non-compliant samples ..................................................................... 107
14.3.2. ARfD exceedances and Actions taken ............................................................................... 107
14.4. Quality assurance ............................................................................................................ 107
14.5. Processing Factors (PF) ................................................................................................... 108
15. Iceland ......................................................................................................................... 108
15.1. Objective and design of the national control programme ................................................... 108
15.1.1. Objective ........................................................................................................................ 108
15.1.2. Design ............................................................................................................................ 108
15.2. PPMP PO P M ŃMMNP RPO PO M P 109
15.2.1. Key findings .................................................................................................................... 109
15.2.2. Interpretation of the results ............................................................................................. 109
15.2.3. FMMNP RPO PO M P ................................................................... 109
15.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................. 109
15.3.1. Possible reasons for non-compliant samples ..................................................................... 109
15.3.2. Actions taken .................................................................................................................. 110
15.4. Quality assurance ............................................................................................................ 111
15.5. Additional information ..................................................................................................... 111
16. Ireland ......................................................................................................................... 111
16.1. Objective and design of the national control programme ................................................... 111
16.1.1. Objective ........................................................................................................................ 111
16.1.2. Design ............................................................................................................................ 112
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 7 EFSA Supporting publication 2022:EN-721616.2. PPMP PO P M ŃMMNP RPO PO M P 112
16.2.1. Key findings .................................................................................................................... 112
16.2.2. Interpretation of the results ............................................................................................. 117
16.2.3. Comparability with the previous year results ..................................................................... 118
16.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 118
16.3.1. Possible reasons for non-compliant samples ..................................................................... 118
16.3.2. ARfD exceedances .......................................................................................................... 119
16.3.3. Actions taken .................................................................................................................. 119
16.4. Quality assurance ............................................................................................................ 119
17. Italy .............................................................................................................................. 119
17.1. Objective and design of the national control programme ................................................... 119
17.2. PPMP PO P M ŃMMNP RPO PO M P 120
17.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 123
17.4. Quality assurance ............................................................................................................ 125
17.5. Processing factors ........................................................................................................... 126
18. Latvia ........................................................................................................................... 127
18.1. Objective and design of the national control programme ................................................... 127
18.1.1. Objective ........................................................................................................................ 127
18.1.2. Design ............................................................................................................................ 127
18.2. Key findings, interpretation of the results and comparability with the previous year results .. 128
18.2.1. Key findings .................................................................................................................... 128
18.2.2. Interpretation of the results ............................................................................................. 128
18.2.3. Comparability with the previous year results ..................................................................... 129
18.3. Non-compliant samples: possible reasons and actions taken .............................................. 129
18.4. Quality assurance ............................................................................................................ 129
18.5. Processing factors (PF) .................................................................................................... 129
18.6. Note on confidentiality of certain control data submitted by reporting country .................... 130
19. Lithuania ...................................................................................................................... 130
19.1. Key findings, interpretation of the results and ŃMMNP RPO PO M P 130
19.2. Quality assurance ............................................................................................................ 131
20. Luxembourg................................................................................................................. 131
20.1. Objective and design of the national control programme ................................................... 133
20.1.1. Objective ........................................................................................................................ 133
20.1.2. Design ............................................................................................................................ 133
20.2. Key findings, interpretation of the results and comparability with the previous year results .. 134
20.2.1. Key findings .................................................................................................................... 134
20.2.2. Interpretation of the results ............................................................................................. 135
20.2.3. Comparability with the previous year results ..................................................................... 136
20.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................. 136
20.4. Quality assurance ............................................................................................................ 137
20.5. Processing factors (PF) .................................................................................................... 137
20.6. Note on confidentiality of certain control data submitted by reporting country .................... 137
21. Malta ............................................................................................................................ 137
21.1. Objective and design of the national control programme ................................................... 137
21.1.1. Objective ........................................................................................................................ 137
21.1.2. Design ............................................................................................................................ 138
21.2. Key findings, interpretation of the results and comparability with the previous year results .. 139
21.2.1. Key findings .................................................................................................................... 139
21.2.2. Interpretation of the results ............................................................................................. 139
21.2.3. Comparability with the previous year results ..................................................................... 140
21.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 141
21.3.1. Residues found ............................................................................................................... 141
21.3.2. Possible reasons for non-compliant samples ..................................................................... 141
21.4. Actions taken ..................................................................................................................... 141
21.5. Quality assurance .............................................................................................................. 142
22. The Netherlands .......................................................................................................... 142
22.1. Objective and design of the national control programme ................................................... 142
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 8 EFSA Supporting publication 2022:EN-721622.2. Key findings, interpretation of the results and comparability with the previous year results .. 143
22.3. Actions taken .................................................................................................................. 144
22.4. Quality assurance ............................................................................................................ 145
22.5. Processing factors (PF) .................................................................................................... 145
23. Norway ......................................................................................................................... 145
23.1. Objective and design of the national control programme ................................................... 145
23.1.1. Objective ........................................................................................................................ 145
23.1.2. Design ............................................................................................................................ 145
23.2. PPMP PO P M ŃMMNP RPO PO M P 146
23.2.1. Key findings .................................................................................................................... 146
23.2.2. Interpretation of the results ............................................................................................. 146
23.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................. 147
23.3.1. Possible reasons for non-compliant samples ..................................................................... 147
23.3.2. ARfD exceedances .......................................................................................................... 148
23.3.3. Actions taken .................................................................................................................. 148
23.4. Quality assurance ............................................................................................................ 148
23.5. Processing factors (PF) .................................................................................................... 148
23.6. Additional information ..................................................................................................... 149
24. Poland .......................................................................................................................... 150
24.1. Objective and design of the national control programme ................................................... 150
24.2. Key findings, interpretation of the results and comparability with the previous M P 150
24.2.1. Key findings .................................................................................................................... 150
24.2.2. Interpretation of the results ............................................................................................. 152
24.2.3. Comparability with the previous year results ..................................................................... 153
24.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 153
24.3.1. Possible reasons for non-compliant samples ..................................................................... 153
24.3.2. ARfD exceedances .......................................................................................................... 154
24.3.3. Actions taken .................................................................................................................. 154
24.4. Quality assurance ............................................................................................................ 155
24.5. Processing Factors (PF) ................................................................................................... 155
25. Portugal ....................................................................................................................... 156
25.1. Objective and design of the national control programme ................................................... 156
25.2. Key findings, interpretation of the results and comparison with the previous year results .... 156
25.2.1. Key findings .................................................................................................................... 156
25.2.2. Comparison with previous results ..................................................................................... 157
25.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken (Coordinated
and National Program) .................................................................................................... 158
25.3.1. Possible reasons for non-compliant samples ..................................................................... 158
25.3.2. ARfD exceedances (Coordinated and National Program) .................................................... 159
25.3.3. Actions taken .................................................................................................................. 159
25.4. Quality assurance ............................................................................................................ 160
25.5. Additional information ..................................................................................................... 160
26. Romania ....................................................................................................................... 160
26.1. Objective and design of the national control programme ................................................... 160
26.1.1. Design ............................................................................................................................ 161
26.2. Key findings, interpretation of the results and comparability with the previous year results .. 162
26.2.1. Key findings .................................................................................................................... 162
26.2.2. Interpretation of the results ............................................................................................. 162
26.2.3. Comparability with the previous year results ..................................................................... 163
26.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 163
26.3.1. Possible reasons for non-compliant samples ..................................................................... 163
26.3.2. Actions taken .................................................................................................................. 165
26.4. Quality assurance ............................................................................................................ 166
27. Slovakia ....................................................................................................................... 167
27.1. Objective and design of the national control programme ................................................... 167
27.2. PPMP PO P M ŃMMNP RPO PO M P 167
27.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken.................... 168
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 9 EFSA Supporting publication 2022:EN-721627.2.1. ARfD exceedances .......................................................................................................... 169
27.2.2. Actions taken .................................................................................................................. 169
27.3. Quality assurance ............................................................................................................ 170
27.4. Processing factors ........................................................................................................... 170
28. Slovenia ....................................................................................................................... 171
28.1. Objective and design of the national control programme ................................................... 171
28.1.1. Objective ........................................................................................................................ 171
28.1.2. Design ............................................................................................................................ 172
28.2. PPMP PO P M ŃMMNP RPO PO M P 173
28.2.1. Key findings .................................................................................................................... 173
28.2.2. Interpretation of the results ............................................................................................. 173
28.2.3. Comparability with the previous year results ..................................................................... 174
28.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................. 174
28.3.1. Possible reasons for non-compliant samples ..................................................................... 174
28.3.2. ARfD exceedances .......................................................................................................... 175
28.3.3. Actions taken .................................................................................................................. 175
28.4. Quality assurance ............................................................................................................ 175
28.5. Processing Factors (PF) ................................................................................................... 176
29. Spain ............................................................................................................................ 176
29.1. Objective and design of the national control programme ................................................... 176
29.2. Key findings, interpretation of the results and comparability with the previous year results .. 177
29.2.1. Key findings .................................................................................................................... 178
29.2.2. Interpretation of the results ............................................................................................. 179
29.2.3. Comparability with the previous year results ..................................................................... 179
29.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 180
29.3.1. Possible reasons for non-compliant samples ..................................................................... 180
29.3.2. Actions taken .................................................................................................................. 181
29.4. Quality assurance ............................................................................................................ 181
29.5. Processing Factors (PF) ................................................................................................... 182
30. Sweden ........................................................................................................................ 183
30.1. Objective and design of the national control programme ................................................... 183
30.1.1. Objective ........................................................................................................................ 183
30.1.2. Design ............................................................................................................................ 183
30.2. Key findings, interpretation of the results and comparability with the previous year results .. 183
30.2.1. Key findings .................................................................................................................... 183
30.2.2. Interpretation of the results ............................................................................................. 184
30.2.3. Comparability with the previous year results ..................................................................... 185
30.3. Non-compliant samples: possible reasons, ARfD exceedances and actions taken ................. 185
30.3.1. Possible reasons for non-compliant samples ..................................................................... 185
30.3.2. ARfD exceedances .......................................................................................................... 186
30.3.3. Actions taken .................................................................................................................. 186
30.4. Quality assurance ............................................................................................................ 186
30.5. Processing Factors (PF) ................................................................................................... 187
31. United Kingdom ........................................................................................................... 188
31.1. Objective and design of the national control programme ................................................... 188
31.2. PPMP PO P M ŃMMNP RPO PO M P 189
31.2.1. Key findings .................................................................................................................... 189
31.2.2. Interpretation of the results ............................................................................................. 190
31.2.3. Comparability with the previous year results ..................................................................... 191
31.3. Non-compliant samples: possible reasons, acute reference dose (ARfD) exceedances and
actions taken .................................................................................................................. 191
31.3.1. Possible reasons for non-compliant samples ..................................................................... 191
31.3.2. ARfD exceedances .......................................................................................................... 192
31.3.3. Actions taken .................................................................................................................. 192
31.4. Quality assurance ............................................................................................................ 192
31.5. Processing Factors (PF) ................................................................................................... 193
31.6. Additional Information ..................................................................................................... 193
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 10 EFSA Supporting publication 2022:EN-7216References ................................................................................................................................. 194
Abbreviations ............................................................................................................................. 195
2020 National Summary Report on Pesticide Residues
www.efsa.europa.eu/publications 11 EFSA Supporting publication 2022:EN-7216Introduction
1.1. Background and Terms of Reference as provided by the requestor
In accordance with Article 31 of Regulation (EC) No. 396/2005, Member States shall submit theirupdated national control programme for pesticide residues to EFSA and publish all results of the
national residue monitoring on the internet. EFSA decided to compile in a technical report additional
information provided by the reporting countries. In November 2019 SCoPAFF pesticide residue
meeting the usefulness of this document was highlighted. To harmonise the whole document layout M P M P MŃŃ P PO PŃOŃM P P M ŃOM PO documents provided by the reporting countries; however, the content submitted was not amended. This Technical Report is complementary to the scientific report on the findings of the 2020 control year (EFSA, 2022).1.2. Interpretation of the Terms of Reference
This report is a compilation of the national summary reports as provided by the national competent authorities (see Appendix A in EFSA, 2022).There might be a discrepancy between the information provided by reporting countries and the
information published in the 2020 European Union Report on Pesticide Residues on food (EFSA,
2022), because EFSA included additional data-cleaning steps in the preparation of the European Union
Report to ensure that the results reported by the 30 countries were comparable. So, these data- cleaning steps might have an impact on the overall results, such as the maximum residue level (MRL)compliance rates. By means of this technical report, reporting countries can explain possible
differences to its dataAustria
2.1. Objective and design of the national control programme
The national pesticide monitoring is conducted according to a nation-wide sampling plan designed by the Austrian Agency for Health and Food Safety in cooperation with the Federal Ministry of Social Affairs, Health, Care and Consumer Protection. The plan is based on data for dietary consumption,quotesdbs_dbs24.pdfusesText_30
[PDF] Ceredas et le Marathon des Sables : Les raisons d`un engagement
[PDF] CEREGE - Centre de Recherche en Gestion
[PDF] Cérémonial de remise des ordres nationaux et de la Médaille Militaire
[PDF] cérémonial et traditions - Anciens Et Réunions
[PDF] cérémonie - Sciences Po Strasbourg - Anciens Et Réunions
[PDF] cérémonie 19 mars 2016
[PDF] Cérémonie commémorative - Aigues
[PDF] CEREMONIE COMMEMORATIVE A LA MEMOIRE DES 80 - FR-ICI - France
[PDF] Cérémonie commémorative du 19 mars 1962 "Journée du souvenir"
[PDF] Cérémonie Commémorative du 8 mai 1945
[PDF] Cérémonie de béatification de Mgr Alvaro del Portillo à Madrid, le 27
[PDF] Cérémonie de départ du Préfet Gilles Lagarde
[PDF] Cérémonie de fin de formation et de baptême de la 20ème
[PDF] Cérémonie de la citoyenneté
[PDF] Cérémonie de la Citoyenneté - Mairie de Saint
[PDF] CEREGE - Centre de Recherche en Gestion
[PDF] Cérémonial de remise des ordres nationaux et de la Médaille Militaire
[PDF] cérémonial et traditions - Anciens Et Réunions
[PDF] cérémonie - Sciences Po Strasbourg - Anciens Et Réunions
[PDF] cérémonie 19 mars 2016
[PDF] Cérémonie commémorative - Aigues
[PDF] CEREMONIE COMMEMORATIVE A LA MEMOIRE DES 80 - FR-ICI - France
[PDF] Cérémonie commémorative du 19 mars 1962 "Journée du souvenir"
[PDF] Cérémonie Commémorative du 8 mai 1945
[PDF] Cérémonie de béatification de Mgr Alvaro del Portillo à Madrid, le 27
[PDF] Cérémonie de départ du Préfet Gilles Lagarde
[PDF] Cérémonie de fin de formation et de baptême de la 20ème
[PDF] Cérémonie de la citoyenneté
[PDF] Cérémonie de la Citoyenneté - Mairie de Saint
